Wells Fargo & Company Foghorn Therapeutics Inc. Transaction History

Wells Fargo & Company

  • $507 Billion
  • Q3 2025

A detailed history of Wells Fargo & Company transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 24,474 shares of FHTX stock, worth $114,783. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,474
Previous 21,043 16.3%
Holding current value
$114,783
Previous $98,000 21.43%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$4.58 - $6.5 $15,713 - $22,301
3,431 Added 16.3%
24,474 $119,000
Q2 2025

Aug 14, 2025
BUY
$3.15 - $4.9 $15,457 - $24,044
4,907 Added 30.41%
21,043 $98,000
Q1 2025

May 13, 2025
BUY
$3.52 - $6.16 $1,038 - $1,817
295 Added 1.86%
16,136 $58,000
Q4 2024

Feb 12, 2025
BUY
$4.61 - $9.35 $18,246 - $37,007
3,958 Added 33.31%
15,841 $74,000
Q3 2024

Nov 13, 2024
BUY
$4.8 - $9.99 $12,532 - $26,083
2,611 Added 28.16%
11,883 $110,000
Q2 2024

Aug 13, 2024
BUY
$5.05 - $8.0 $16,124 - $25,544
3,193 Added 52.53%
9,272 $53,000
Q1 2024

May 10, 2024
BUY
$2.82 - $7.94 $2,292 - $6,455
813 Added 15.44%
6,079 $40,000
Q4 2023

Feb 09, 2024
BUY
$2.94 - $6.76 $3,528 - $8,112
1,200 Added 29.51%
5,266 $33,000
Q3 2023

Nov 13, 2023
SELL
$5.0 - $9.87 $22,080 - $43,585
-4,416 Reduced 52.06%
4,066 $20,000
Q2 2023

Aug 15, 2023
SELL
$5.37 - $8.84 $4,242 - $6,983
-790 Reduced 8.52%
8,482 $59,000
Q1 2023

May 12, 2023
BUY
$4.66 - $8.99 $18,094 - $34,908
3,883 Added 72.05%
9,272 $57,000
Q4 2022

Feb 13, 2023
BUY
$5.44 - $9.46 $27,319 - $47,508
5,022 Added 1368.39%
5,389 $34,000
Q3 2022

Nov 14, 2022
SELL
$7.52 - $18.01 $1,466 - $3,511
-195 Reduced 34.7%
367 $3,000
Q2 2022

Aug 12, 2022
SELL
$8.48 - $16.84 $30,053 - $59,680
-3,544 Reduced 86.31%
562 $8,000
Q1 2022

May 16, 2022
SELL
$8.87 - $22.1 $60,386 - $150,456
-6,808 Reduced 62.38%
4,106 $63,000
Q4 2021

Feb 14, 2022
BUY
$10.79 - $22.87 $117,762 - $249,603
10,914 New
10,914 $250,000
Q3 2021

Nov 15, 2021
SELL
$8.33 - $15.02 $316 - $570
-38 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$9.32 - $13.26 $20,625 - $29,344
-2,213 Reduced 98.31%
38 $0
Q1 2021

May 13, 2021
SELL
$11.8 - $23.11 $17,652 - $34,572
-1,496 Reduced 39.93%
2,251 $30,000
Q4 2020

Feb 09, 2021
BUY
$15.12 - $25.88 $56,654 - $96,972
3,747 New
3,747 $76,000

Others Institutions Holding FHTX

# of Institutions
88
Shares Held
37M
Call Options Held
100
Put Options Held
0
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $195M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email